Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Foie » Hépatite 05. Août 2020
Recherche
Gastroplattform
Hépatite
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 3549  Page précédente Page suivante
   
   Articles 1 - 20 / 70969  
   
Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals.
Aliment Pharmacol Ther
Park JS, Gayam V, Pan CQ.
PMID: 32743822 [PubMed - as supplied by publisher]


Hepatitis D virus seroprevalence in Egyptian HBsAg-positive children: a single-center study.
Arch Virol
Fouad HM, Ahmed A, Reyad EM, ElSadek SM, Khattab RA, El Damasy DA.
PMID: 32743697 [PubMed - as supplied by publisher]


Associations between polymorphisms in IL-10 gene and the risk of viral hepatitis: a meta-analysis.
Gut Pathog
Zhang Y, Chen L, Chen H.
PMID: 32742307 [PubMed]


Bayesian Network to Predict Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients.
J Viral Hepat
Huang Y, Li X, Zheng X, Tian X, Yu M, Sha L, Liu Y, Chong Y, Hao Y, You X.
PMID: 32741055 [PubMed - as supplied by publisher]


Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data.
Clin Rheumatol
Lau CS, Chen YH, Lim K, de Longueville M, Arendt C, Winthrop K.
PMID: 32740672 [PubMed - as supplied by publisher]


Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.
Contemp Clin Trials
Dasarathy S, Mitchell MC, Barton B, McClain CJ, Szabo G, Nagy LE, Radaeva S, McCullough AJ.
PMID: 32739495 [PubMed - as supplied by publisher]


A radiomics model of liver CT to predict risk of hepatic encephalopathy secondary to hepatitis B related cirrhosis.
Eur J Radiol
Cao JM, Yang JQ, Ming ZQ, Wu JL, Yang LQ, Chen TW, Li R, Ou J, Zhang XM, Mu QW, Li HJ, Hu J.
PMID: 32738462 [PubMed - as supplied by publisher]


The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis.
BMC Gastroenterol
Peng C, Li Z, Xie Z, Wang Z, Ye Y, Li B, Li W.
PMID: 32736604 [PubMed - in process]


Care seeking and treatment for hepatitis C infection in Rwanda: A qualitative study of patient experiences.
Glob Public Health
Van Nuil JI, Shumbusho F, Kateera F, Mukuralinda A, Kabahizi J, Muvunyi CM, Musabeyezu E, Mukabatsinda C, Mbituyumuremi A, Nsanzimana S, Mukerjee J, Gupta N.
PMID: 32735478 [PubMed - as supplied by publisher]


Association between inosine triphosphatase rs1127354 polymorphisms and ribavirin-induced anaemia and outcome in hepatitis C virus-infected patients: A meta-analysis.
J Clin Pharm Ther
Ma Z, Sun Y, Du P, Li X.
PMID: 32735044 [PubMed - as supplied by publisher]


Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead.
Viruses
Liu CJ, Chen PJ.
PMID: 32731536 [PubMed - in process]


Hepatitis E Virus: How It Escapes Host Innate Immunity.
Vaccines (Basel)
Lhomme S, Migueres M, Abravanel F, Marion O, Kamar N, Izopet J.
PMID: 32731452 [PubMed]


The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections.
Biology (Basel)
Glowacka P, Rudnicka L, Warszawik-Hendzel O, Sikora M, Goldust M, Gajda P, Stochmal A, Blicharz L, Rakowska A, Olszewska M.
PMID: 32731331 [PubMed]


Global hepatitis C elimination: an investment framework.
Lancet Gastroenterol Hepatol
Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus JV, Atun R, Baptista-Leite R, 't Hoen E, Hutchinson SJ, Aufegger L, Peck R, Sohn AH, Swan T, Thursz M, Lesi O, Sharma M, Thwaites J, Wilson DP, Hellard M.
PMID: 32730786 [PubMed - as supplied by publisher]


A model of the economic benefits of global hepatitis C elimination: an investment case.
Lancet Gastroenterol Hepatol
Scott N, Kuschel C, Pedrana A, Schroeder S, Howell J, Thompson A, Wilson DP, Hellard M.
PMID: 32730785 [PubMed - as supplied by publisher]


Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Lancet Gastroenterol Hepatol
Palayew A, Razavi H, Hutchinson SJ, Cooke GS, Lazarus JV.
PMID: 32730784 [PubMed - as supplied by publisher]


Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma.
PLoS Biol
Iwanami S, Kitagawa K, Ohashi H, Asai Y, Shionoya K, Saso W, Nishioka K, Inaba H, Nakaoka S, Wakita T, Diekmann O, Iwami S, Watashi K.
PMID: 32730280 [PubMed - in process]


Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019.
MMWR Morb Mortal Wkly Rep
Sandhu HS, Roesel S, Sharifuzzaman M, Chunsuttiwat S, Tohme RA.
PMID: 32730237 [PubMed - indexed for MEDLINE]


Point-of-care hepatitis C screening with direct access referral to improve linkage of care among people with substance misuse: a pilot randomised study.
Singapore Med J
Hsiang JC, Sinnaswami P, Lee MY, Zhang MM, Quek KE, Tan KH, Wong YM, Thurairajah PH.
PMID: 32729280 [PubMed - as supplied by publisher]


Clinical effects of simvastatin in chronic hepatitis C patients receiving sofosbuvir/daclatasvir combination. A randomized, placebo-controlled, double-blinded study.
Clin Exp Hepatol
Mohamed HZ, Sabri NA, Zaki HM, Shaheen SM.
PMID: 32728626 [PubMed]


   
   Articles 1 - 20 / 70969    Page 1 de 3549  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1